Ⅱ~Ⅳ期乳腺癌患者中Panagen激活继发性免疫反应和白细胞活性的Ⅱ期多中心双盲安慰剂对照临床研究
评价者: 欧阳取长1, 文献合成者: 胡哲煜1, 朱文珍2

Results of Multicenter Double-Blind Placebo-Controlled PhaseⅡ Clinical Trial of Panagen Preparation to Evaluate Its Leukostimulatory Activity and Formation of The Adaptive Immune Response in Patients with Stage Ⅱ~ⅣBreast Cancer
Reviewer: OUYANG Qu-chang1, Literature Co-workers: HU Zhe-yu1, ZHU Wen-zhen2